Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
43 studies found for:    "sporadic hemiplegic migraine" OR "Migraine with Aura"
Show Display Options
Rank Status Study
1 Active, not recruiting Women With Migraine With Aura Neuroimaging Study
Condition: Migraine With Aura
Intervention:
2 Recruiting Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
Condition: Migraine With Aura
Interventions: Drug: sumatriptan with naprosyn;   Drug: placebo
3 Unknown  Functional MRI and MRA in Migraine With Aura
Condition: Migraine With Aura
Intervention:
4 Completed Tonabersat in the Prophylaxis of Migraine With Aura
Condition: Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
5 Completed Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)
Conditions: Familial Hemiplegic Migraine;   Migraine With Aura;   Healthy
Intervention: Drug: CGRP
6 Recruiting Induction of Migraine Aura With Cilostazol
Conditions: Migraine With Aura;   Stroke
Interventions: Drug: Cilostazol;   Drug: Placebo
7 Completed
Has Results
Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura
Condition: Migraine With Aura
Interventions: Device: Active Transcranial Magnetic Stimulation (TMS) Device;   Device: Sham TMS Device
8 Terminated PRIMA PFO Migraine Trial
Conditions: Migraine;   Migraine With Aura;   Patent Foramen Ovale;   PFO
Intervention: Device: AMPLATZER® PFO Occluder Device
9 Completed
Has Results
Study of NXN 188 for the Treatment of Migraine With Aura
Condition: Migraine With Aura
Interventions: Drug: NXN-188;   Drug: placebo;   Drug: sumatriptan succinate
10 Unknown  Migraine and Endothelial Dysfunction
Condition: Migraine With Aura
Intervention:
11 Completed
Has Results
Comorbidities Associated With Migraine and Patent Foramen Ovale (CAMP)
Conditions: Migraine With Aura;   Patent Foramen Ovale
Intervention:
12 Recruiting IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice
Conditions: Headache Disorders, Primary;   Migraine With Aura;   Migraine Without Aura;   Tension-Type Headache
Intervention:
13 Completed Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
14 Completed Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
Conditions: Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Maxalt 10mg MLT plus Caffeine 75mg;   Drug: Maxalt 10mg MLT plus Placebo;   Drug: Placebo + Placebo
15 Completed Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Placebo;   Drug: Eletriptan HBr 40 mg;   Drug: Eletriptan HBr 80 mg
16 Recruiting Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI
Conditions: Migraine With Aura;   Migraine Without Aura;   Chronic Migraine
Intervention: Other: Brain MRI
17 Recruiting Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department
Conditions: Probable Migraine;   Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Ketorolac Tromethamine;   Drug: Metoclopramide
18 Completed Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Laxymig ER (drug)
19 Completed Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
20 Unknown  Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
Conditions: Migraine;   Migraine Headache;   Migraine Disorders;   Migraine With Aura;   Migraine Without Aura
Interventions: Drug: AST-726 Low dose;   Drug: AST-726 High dose;   Drug: AST-726 Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years